Theranos Isn’t the Only Diagnostics Company Exploiting Regulatory Loopholes

Theranos isn’t alone in avoiding regulation using an easily exploited loophole — in fact, it’s just one among many.

Pathway Genomics, Admera Health and Strand Life Sciences are diagnostics companies that offer cancer tests that impact people’s health care decisions. None of these companies has published data about its tests in peer-reviewed journals. Nor were any of these companies required to show regulators that their tests worked before they started marketing them to patients and physicians. That’s because each of these companies has been making use of what’s known as the “laboratory developed test” loophole — which makes avoiding pre-market verification downright easy.

Read the rest of this post on the original site »

This article originally appeared on Recode.net.

Explanatory journalism is a public good

At Vox, we believe that everyone deserves access to information that helps them understand and shape the world they live in. That's why we keep our work free. Support our mission and help keep Vox free for all by making a financial contribution to Vox today.

One-Time Monthly Annual

$95/year

$120/year

$250/year

$350/year

Other

$

Yes, I'll give $120/year

Yes, I'll give $120/year

We accept credit card, Apple Pay, and Google Pay. You can also contribute via